Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Soraya M Samii , Javier E Banchs Added: 3 years ago
The use of implantable devices to treat arrhythmias started with the implantable pacemaker back in the late 1950s. The risks and costs of implantation limited the indications for the procedure initially. A similar pattern was seen with the initial implantable cardioverter-defibrillators (ICDs) in the early 1980s. In the late 1990s, technology of both these devices focused on the management of… View more

Electrophysiology & Arrhythmia
TCT 23: 5 Trials That Changed My Practice
Author(s): Kendra J Grubb Added: 5 months ago
TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice. Trials covered in detail include: PARTNER 3 & EVOLUT Low-Risk ALIGN-AR TENDYNE APOLLO TRILUMINATE Recorded remotely… View more

Intervention
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention
MXR for Cardiology
Author(s): David Bloom , Michael K Southworth , Jonathan R Silva , et al Added: 1 year ago

Electrophysiology & Arrhythmia
James C Moon
Job title: Clinical Director of Imaging
Personal History Prof James C. Moon is a Cardiology Professor at University College London and Clinical Director of Imaging at Barts Heart Centre. He is known for the use of cardiac MRI and for developing mapping techniques to bridge clinical and basic investigators.5 Academic History Professor Moon graduated with a BA from the University of Cambridge in 1992. He then went on to… View more
Who should be referred for TAVR
Author(s): Colin M Barker , Michael J Reardon Added: 3 years ago
Aortic stenosis (AS) has a long latent period and then rapid progression with high mortality once symptoms appear.1 The absence of an effective medical therapy for symptomatic severe AS led to a class I indication for aortic valve replacement (AVR) in both the US and European guidelines.2,3 Unfortunately, a study by Bach et al. in 2009 found that up to half of patients with symptomatic severe AS… View more

Vascular Disease and Surgery

Intervention
TRISCEND Study: 6Mo Outcomes Show TR Reduction in Majority of Patients
Author(s): Susheel Kodali Added: 2 years ago
Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND study.Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid… View more

Intervention
Jeff Healey
Jeff Healey serves as the director of arrhythmia services and holds the position of associate professor of medicine at McMaster University in Hamilton, Ontario, Canada. As a clinical trialist and member of the Population Health Research Institute, Dr. Healey completed his clinical training in cardiology and electrophysiology at the University of Ottawa Heart Institute. He furthered his academic… View more
Intrepid TMVR: Results Show Improved NYHA Class at 30 Days
Author(s): Firas Zahr Added: 2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral… View more

Intervention
Author(s): Alan J Bank , Kevin V Burns , Ryan M Gage Added: 3 years ago
Cardiac resynchronization therapy (CRT) is a well-accepted and proven therapy for the treatment of patients with advanced heart failure (HF), significant left ventricular (LV) systolic dysfunction, and a wide QRS complex on electrocardiogram (ECG). In this patient population, large multicenter studies have demonstrated that CRT improves symptoms of HF, exercise capacity, LV size and systolic… View more

Imaging & Diagnostics

Heart Failure